Literature DB >> 2647832

Zygomycosis.

M G Rinaldi1.   

Abstract

Zygomycosis represents an excellent example of an opportunistic fungal infection that generally occurs in the debilitated, immunocompromised, or acidotic host. Infections are usually fulminant, with etiologic agents exhibiting predilection for invasion of blood vessels with resultant infarction and necrosis. The spectrum of agents capable of inciding zygomycosis has broadened and the incidence has increased in contemporary medicine. Nevertheless, an increased index of suspicion, better mycological acumen, aggressive surgical debridement of diseased tissue, and prompt therapy with amphotericin B have rendered substantial improvement in the prognosis of an otherwise fatal infectious disease. Rapid and accurate diagnostic techniques and the availability of less toxic, efficacious antifungal agents should be sought after goals for the enhanced management of zygomycosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647832

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  13 in total

1.  Zygomycotic gangrenous cellulitis in a patient with non-insulin dependent diabetes mellitus.

Authors:  O Zimhony; E Israeli; S D Malnick; A Pansky; P Cohen; D Geltner
Journal:  West J Med       Date:  1998-03

2.  An unusual cause of renal failure: Disseminated mucormycosis.

Authors:  Pranav Dalal
Journal:  J Nephropathol       Date:  2012-10-01

3.  Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report.

Authors:  A A Cagatay; S S Oncü; S S Calangu; T T Yildirmak; H H Ozsüt; H H Eraksoy
Journal:  BMC Infect Dis       Date:  2001-11-23       Impact factor: 3.090

4.  Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data.

Authors:  K Voigt; E Cigelnik; K O'donnell
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Clinical experience in invasive fungal infections.

Authors:  Patrícia Pacheco; Ana Sofia Ventura; Teresa Branco; Lucília Gonçalves; Célia Carvalho
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

7.  Zygomycosis: an emerging fungal infection with new options for management.

Authors:  Carol A Kauffman; Anurag N Malani
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

8.  Sequential morphological changes in follow-up CT of pulmonary mucormycosis.

Authors:  Ji Yung Choo; Chang Min Park; Hyun-Ju Lee; Chang Hyun Lee; Jin Mo Goo; Jung-Gi Im
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

9.  Apophysomyces elegans: an emerging zygomycete in India.

Authors:  A Chakrabarti; A Ghosh; G S Prasad; J K David; S Gupta; A Das; V Sakhuja; N K Panda; S K Singh; S Das; T Chakrabarti
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Mucor ramosissimus Samutsevitsch isolated from a thigh lesion.

Authors:  I Weitzman; P Della-Latta; G Housey; G Rebatta
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.